United States Antimony (UAMY) 10-Q 16 May 22 2022 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2022	May 16, 2022
Cover [Abstract]
Entity Registrant Name	UNITED STATES ANTIMONY CORPORATION
Entity Central Index Key	0000101538
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	false
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2022
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2022
Entity Common Stock Shares Outstanding		106,240,361
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	001-08675
Entity Incorporation State Country Code	MT
Entity Tax Identification Number	81-0305822
Entity Interactive Data Current	Yes
Entity Address Address Line 1	P.O. Box 643
Entity Address City Or Town	Thompson Falls
Entity Address State Or Province	MT
Entity Address Postal Zip Code	59873
City Area Code	406
Local Phone Number	827-3523
Security 12b Title	Common Stock, $0.01 par value
Trading Symbol	UAMY
Security Exchange Name	NYSEAMER

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
CURRENT ASSETS
Cash and cash equivalents	$ 21,334,353	$ 21,363,048
Certificates of deposit	259,210	259,210
Accounts receivable	1,475,853	891,314
Inventories (NOTE 5)	1,026,980	1,055,420
Total current assets	24,096,396	23,568,992
Properties, plants and equipment, net	11,102,124	11,133,733
Restricted cash for reclamation bonds	57,281	57,281
IVA receivable and other assets	283,744	242,721
Total assets	35,539,545	35,002,727
CURRENT LIABILITIES:
Accounts payable	1,107,574	1,385,752
Accrued liabilities	624,817	621,873
Long-term debt, current portion	12,287	13,230
Total current liabilities	1,744,678	2,020,855
Long-term debt, net of current portion	198,806	201,920
Stock payable to directors for services	140,625	112,500
Asset retirement obligations and accrued reclamation costs (NOTE 7)	300,381	298,649
Total liabilities	2,384,490	2,633,924
STOCKHOLDERS' EQUITY
Common stock, $.001 par value; 300,000,000 shares authorized; 106,240,361 shares issued and outstanding	1,062,402	1,062,402
Additional paid-in capital	63,991,459	63,991,459
Accumulated deficit	(31,925,011)	(32,711,263)
Total stockholders' equity	33,155,055	32,368,803
Total liabilities and stockholders' equity	35,539,545	35,002,727
Series A
STOCKHOLDERS' EQUITY
Preferred stock	0	0
Series B
STOCKHOLDERS' EQUITY
Preferred stock	7,500	7,500
Series C
STOCKHOLDERS' EQUITY
Preferred stock	1,779	1,779
Series D
STOCKHOLDERS' EQUITY
Preferred stock	$ 16,926	$ 16,926

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Common stock, par value	$ 0.001	$ 0.001
Common stock, authorized shares	300,000,000	300,000,000
Common stock, issued shares	106,240,361	106,240,361
Common stock, outstanding shares	106,240,361	106,240,361
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, authorized shares	10,000,000	10,000,000
Series A
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, issued shares	0	0
Preferred stock, outstanding shares	0	0
Series B
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, issued shares	750,000	750,000
Preferred stock, outstanding shares	750,000	750,000
Preferred stock liquidation preference	$ 954,375	$ 952,500
Series C
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, issued shares	177,904	177,904
Preferred stock, outstanding shares	177,904	177,904
Preferred stock liquidation preference	$ 97,847	$ 97,847
Series D
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, issued shares	1,692,672	1,692,672
Preferred stock, outstanding shares	1,692,672	1,692,672
Preferred stock liquidation preference	$ 4,979,632	$ 4,979,632

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
REVENUE	$ 3,580,306	$ 1,253,287
COST OF REVENUE	2,440,918	1,041,130
GROSS PROFIT	1,139,388	212,157
OPERATING EXPENSES:
General and administrative	160,681	170,050
Salaries and benefits	73,135	76,659
Other operating expenses	3,915	184,037
Professional fees	122,077	123,137
TOTAL OPERATING EXPENSES	359,808	553,883
INCOME (LOSS) FROM OPERATIONS	779,580	(341,726)
OTHER INCOME (EXPENSE)
Interest expense	(2,982)	(2,255)
Interest income	9,654	8,493
TOTAL OTHER INCOME (EXPENSE)	6,672	6,238
NET INCOME (LOSS)	786,252	(335,488)
Preferred dividends	(11,819)	(12,162)
Net income (loss) available to common stockholders	$ 774,432	$ (347,650)
Net income (loss) per share of common stock:
Basic and diluted	$ 0.01
Weighted average shares outstanding:
Basic	106,240,361	92,711,336
Diluted	106,389,761	92,711,336

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY (UNAUDITED) - USD ($)	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Retained Earnings (Accumulated Deficit)
Balance, shares at Dec. 31, 2020		2,678,909	75,949,757
Balance, amount at Dec. 31, 2020	$ 7,186,389	$ 26,788	$ 759,496	$ 39,050,899	$ (32,650,794)
Common shares issued for cash, shares			26,290,000
Common shares issued for cash, amount	24,997,000	0	$ 262,900	24,734,100	0
Common stock issuance costs	(1,654,820)	0	$ 0	(1,654,820)	0
Common stock issued for exercise of warrants, shares			3,723,810
Common stock issued for exercise of warrants, amount	1,763,619	0	$ 37,238	1,726,381	0
Net income (loss)	(335,488)	$ 0	$ 0	0	(335,488)
Balance, shares at Mar. 31, 2021		2,678,909	105,963,567
Balance, amount at Mar. 31, 2021	31,956,700	$ 26,788	$ 1,059,634	63,856,560	(32,986,282)
Balance, shares at Dec. 31, 2021		2,620,576	106,240,361
Balance, amount at Dec. 31, 2021	32,368,803	$ 26,205	$ 1,062,402	63,991,459	(32,711,263)
Net income (loss)	786,252	$ 0	$ 0	0	786,252
Balance, shares at Mar. 31, 2022		2,620,576	106,240,361
Balance, amount at Mar. 31, 2022	$ 33,155,055	$ 26,205	$ 1,062,402	$ 63,991,459	$ (31,925,011)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)	$ 786,252	$ (335,488)
Adjustments to reconcile net loss to net cash used by operating activities
Depreciation and amortization	220,150	222,464
Accretion of asset retirement obligation	1,732	1,732
Common stock payable for directors fees	28,125	28,125
Write-down of inventory to net realizable value	0	57,530
Other non-cash items	0	(661)
Changes in operating assets and liabilities:
Accounts receivable	(584,539)	(298,933)
Inventories	28,440	(125,067)
IVA receivable and other assets	(41,023)	(50,546)
Accounts payable	(278,178)	(582,360)
Accrued liabilities	2,944	(80,998)
Export tax assessment payable	0	(1,120,730)
Payable to related parties	0	(164,922)
Net cash provided (used) by operating activities	163,903	(2,449,854)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of properties, plants and equipment	(188,541)	(23,298)
Net cash used by investing activities	(188,541)	(23,298)
CASH FLOWS FROM FINANCING ACTIVITIES:
Change in checks issued and payable	0	(86,685)
Payments on advances from related party	0	(56,216)
Proceeds from issuance of common stock, net of issuance costs	0	23,342,180
Proceeds from exercise of warrants	0	1,763,619
Principal paid on notes payable to bank	0	(100,000)
Principal payments of long-term debt	(4,057)	(12,518)
Net cash provided (used) by financing activities	(4,057)	24,850,380
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	(28,695)	22,377,228
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	21,420,329	722,377
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 21,391,634	$ 23,099,605

NATURE OF OPERATIONS

NATURE OF OPERATIONS	3 Months Ended
	Mar. 31, 2022
NATURE OF OPERATIONS
1. NATURE OF OPERATIONS	NOTE 1 - NATURE OF OPERATIONS AGAU Mines, Inc., predecessor of United States Antimony Corporation (“USAC” or “the Company”), was incorporated in June 1968 as a Delaware corporation to mine gold and silver. USAC was incorporated in Montana in January 1970 to mine and produce antimony products. In June 1973, AGAU Mines, Inc. was merged into USAC. In December 1983, the Company suspended its antimony mining operations when it became possible to purchase antimony raw materials more economically from foreign sources. The principal business of the Company has been the production and sale of antimony products. During 2000, the Company formed a 75% owned subsidiary, Bear River Zeolite Company (“BRZ”), to mine and market zeolite and zeolite products from a mineral deposit in southeastern Idaho. In 2001, an operating plant was constructed at the zeolite site and zeolite production and sales commenced. During 2002, the Company acquired the remaining 25% of BRZ and continued to produce and sell zeolite products. During 2005, the Company formed a 100% owned subsidiary, Antimonio de Mexico S.A. de C.V. (“AM”), to explore and develop potential antimony properties in Mexico. During 2006, the Company acquired 100% ownership in United States Antimony, Mexico S.A. de C.V. (“USAMSA”), which became a wholly-owned subsidiary of the Company. In 2018, the Company acquired 100% ownership in Stibnite Holding Company US Inc. (previously Lanxess Holding Company US Inc.), Antimony Mining and Milling US LLC (previously Lanxess Laurel US LLC), a Delaware limited liability company and Lanxess Laurel de Mexico, S.A. de C.V (“Lanxess Laurel Mexico”), a Mexico corporation, both of which became a wholly-owned subsidiary of the Company. In its operations in Montana, the Company produces antimony oxide, antimony metal, and precious metals. Antimony oxide is a fine, white powder that is used primarily in conjunction with a halogen to form a synergistic flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings and paper. Antimony oxide is also used as a color fastener in paint, as a catalyst for production of polyester resins for fibers and film, as a catalyst for production of polyethylene pthalate in plastic bottles, as a phosphorescent agent in fluorescent light bulbs, and as an opacifier for porcelains. The Company also sells antimony metal for use in bearings, storage batteries and ordnance. In its operations in Idaho, the Company produces zeolite, a group of industrial minerals used in a variety of purposes including soil amendment and fertilizer. Zeolite is also used for water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation and other miscellaneous applications.

SIGNIFICANT ACCOUNTING POLICIES

SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES
2. SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES In the opinion of the Company, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of March 31, 2022, and its results of operations for the three months ended March 31, 2022, and 2021, and cash flows for the three months ended March 31, 2022 and 2021. The condensed consolidated balance sheet at December 31, 2021, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements. These unaudited interim financial statements have been prepared by management in accordance with generally accepted accounting principles used in the United States of America (“U.S. GAAP”). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 filed with the Securities and Exchange Commission on March 31, 2022. This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements. Reclassifications Certain reclassifications have been made to conform prior periods’ amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported. COVID -19 The Company’s operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and elsewhere, causing disruptions to the Company’s business operations and management. These disruptions are most evident in the Company’s ability to retain and house employees and properly manage them while maintaining proper social distancing and with delays in obtaining materials and supplies. The effects of the continued outbreak of COVID-19 and related government responses could also include extended disruptions to supply chains and capital markets, reduced availability of contractors and a prolonged reduction in economic activity. These effects could have a variety of adverse impacts on the Company, including its ability to conduct operations. The Company has taken steps to mitigate the potential risks to suppliers and employees posed by the spread of COVID-19, including work from home policies where appropriate. The Company will continue to monitor developments affecting both its workforce and contractors, and will take additional precautions as necessary. The ultimate impact of COVID-19 depends on factors beyond management’s knowledge or control, including its duration and third-party actions to contain its spread and mitigate its public health effects. Therefore, the Company cannot estimate the potential future impact to its financial position, results of operations and cash flows, but the impacts could be material. New Accounting Pronouncements Accounting standards that have been issued or proposed by the Financial Accounting Standards Board (“FASB”) that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

EARNINGS PER SHARE

EARNINGS PER SHARE	3 Months Ended
	Mar. 31, 2022
Net income (loss) per share of common stock:
3. EARNINGS PER SHARE	NOTE 3– EARNINGS PER SHARE Basic Earnings Per Share (“EPS”) is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur from common shares issuable through stock options and warrants. For the three months ended March 31, 2022, the calculation of diluted income per common share included 149,400 warrants to purchase one share of common stock. At March 31, 2022 and 2021, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive are as follows: March 31, 2022 March 31, 2021 Warrants 9,400,207 2,471,089 Convertible preferred stock 1,692,672 1,751,005 TOTAL POSSIBLE DILUTIVE SHARES 11,092,879 4,222,094

REVENUE RECOGNITION

REVENUE RECOGNITION	3 Months Ended
	Mar. 31, 2022
REVENUE RECOGNITION
4. REVENUE RECOGNITION	NOTE 4 – REVENUE RECOGNITION Products consist of the following: · Antimony: includes antimony oxide, sodium antimonate, antimony trisulfide and antimony metal · Zeolite: includes coarse and fine zeolite crushed in various sizes · Precious metals: includes unrefined and refined gold and silver Sales of products for the three-months ended March 31, 2022 and 2021 were as follows: For the three months ended March 31, 2022 March 31, 2021 Antimony $ 2,828,930 $ 657,107 Zeolite 674,042 519,947 Precious metals 77,334 76,233 TOTAL REVENUE BY PRODUCT $ 3,580,306 $ 1,253,287 The Company’s trade accounts receivable balance related to contracts with customers was $1,475,853 at March 31, 2022 and $891,314 at December 31, 2021. The Company’s products do not involve any warranty agreements and product returns are not typical.

INVENTORIES

INVENTORIES	3 Months Ended
	Mar. 31, 2022
INVENTORIES
5. INVENTORIES	NOTE 5– INVENTORIES Inventories at March 31, 2022 and December 31, 2021 consisted primarily of finished antimony products, antimony metal, antimony ore, and finished zeolite products that are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products, antimony metal and finished zeolite products costs include raw materials, direct labor and processing facility overhead costs and freight. Inventories at March 31, 2022 and December 31, 2021 are as follows: March 31, 2022 December 31, 2021 Antimony Metal $ 397,815 $ 234,461 Antimony Oxide 361,797 439,086 Antimony Ore Concentrates 15,222 119,046 Total antimony 774,834 792,593 Zeolite 252,146 262,827 TOTAL INVENTORIES $ 1,026,980 $ 1,055,420 Antimony oxide and metal inventory consisted of finished product held at the Company’s plants in Montana and Mexico. Antimony concentrates and ore were held primarily at sites in Mexico. The Company’s zeolite inventory consists of saleable zeolite material.

PROPERTIES, PLANTS AND EQUIPMEN

PROPERTIES, PLANTS AND EQUIPMENT	3 Months Ended
	Mar. 31, 2022
PROPERTIES, PLANTS AND EQUIPMENT
6. PROPERTIES, PLANTS AND EQUIPMENT	NOTE 6 – PROPERTIES, PLANTS AND EQUIPMENT The major components of the Company’s properties, plants and equipment by segment at March 31, 2022 and December 31, 2021 are shown below: Antimony Segment Zeolite Segment Precious Metals March 31, 2022 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,713,328 $ 8,774,212 $ 3,881,612 $ 1,338,774 $ 15,707,926 Buildings 243,248 613,449 1,093,554 - 1,950,251 Mineral rights and interests - 848,012 - - 848,012 Land and other 2,431,387 2,478,044 16,753 - 4,926,184 4,387,963 12,713,717 4,991,919 1,338,774 23,432,373 Accumulated depreciation (2,742,278 ) (5,761,012 ) (3,359,362 ) (467,597 ) (12,330,249 ) $ 1,645,685 $ 6,952,705 $ 1,632,557 $ 871,177 $ 11,102,124 Antimony Segment Zeolite Segment Precious Metals December 31, 2021 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,684,977 $ 8,757,775 $ 3,853,056 $ 1,330,394 $ 15,626,202 Buildings 243,248 613,449 986,736 - 1,843,433 Mineral rights and interests - 848,012 - - 848,012 Land and other 2,431,387 2,478,044 16,753 - 4,926,184 4,359,612 12,697,280 4,856,545 1,330,394 23,243,831 Accumulated depreciation (2,732,809 ) (5,622,555 ) (3,314,658 ) (440,076 ) (12,110,098 ) $ 1,626,803 $ 7,074,725 $ 1,541,887 $ 890,318 $ 11,133,733 At March 31, 2022 and December 31, 2021, the Company had $956,965 and $665,175, respectively, of assets that were not yet placed in service and have not yet been depreciated.

ASSET RETIREMENT OBLIGATION AND

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS	3 Months Ended
	Mar. 31, 2022
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS
7. ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS	NOTE 7 – ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS Changes in the asset retirement obligation for the three months ended March 31, 2022 and 2021 are as follows: Three months ended March 31, 2022 2021 Asset retirement obligation, beginning of period $ 191,149 $ 184,219 Accretion expense 1,732 1,732 Asset retirement obligation, end of period $ 192,881 $ 185,951 The Company’s total asset retirement obligation and accrued reclamation costs of $300,318 and $298,649, at March 31, 2022 and December 31, 2021, respectively, include reclamation obligations for the Idaho and Montana operations of $107,500.

DEBT

DEBT	3 Months Ended
	Mar. 31, 2022
DEBT
8. DEBT	NOTE 8 – DEBT Long term debt at March 31, 2022 and December 31, 2021 is as follows: March 31, 2022 December 31, 2021 Promissory note payable to First Security Bank of Missoula, bearing interest at 2.25%, payable in 59 monthly installments of $1,409 with a final payment of $152,726 maturing November 9, 2026; collateralized by a lien on Certificate of Deposit $ 211,093 $ 215,150 Less current portion (12,287 ) (13,230 ) Long term portion $ 198,806 $ 201,920 At March 31, 2022, principal payments on debt are due as follows: Twelve months ending March 31, Principal payment 2023 $ 12,287 2024 12,555 2025 12,852 2026 13,144 2027 160,255 $ 211,093

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Mar. 31, 2022
COMMITMENTS AND CONTINGENCIES
9. COMMITMENTS AND CONTINGENCIES	NOTE 9 – COMMITMENTS AND CONTINGENCIES From time to time, the Company is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). Using appropriate regulatory channels, management may contest these proposed assessments. At March 31, 2022 and December 31, 2021, the Company had accrued liabilities of $1,270 and $Nil, respectively, relating to such assessments, which is included in accrued liabilities on the condensed consolidated balance sheets. The Company pays various royalties on the sale of zeolite products. On a combined basis, royalties vary from 8%-13%. During the three months ended March 31, 2022 and 2021, the Company incurred royalty expense of $62,030 and $62,130, respectively. Royalty expense is included in cost of goods sold on the Statement of Operations. At March 31, 2022 and December 31, 2021, the Company had accrued royalties payable of $381,054 and $346,242, respectively, which is included in accrued liabilities on the condensed consolidated balance sheets. The Company is currently in negotiations with certain royalty holders to modify the terms of the agreements.

STOCKHOLDERS EQUITY

STOCKHOLDERS EQUITY	3 Months Ended
	Mar. 31, 2022
STOCKHOLDERS' EQUITY
10. STOCKHOLDERS' EQUITY	NOTE 10 – STOCKHOLDERS’ EQUITY During the three months ended March 31, 2021, the Company sold shares of its common stock in two separate transactions: on February 3, 2021, 15,300,000 shares were sold at $0.70 for gross proceeds of $10,710,000; and on February 18, 2021, 10,990,000 shares were sold at $1.30 for gross proceeds of $14,287,000. A total of $1,654,820 of issuance costs were incurred on these sales. During the three months ended March 31, 2021, the Company issued 3,723,810 shares of common stock and received $1,763,619 in cash from the exercise of warrants. During the three months ended March 31, 2022 and March 31, 2021, the Company expensed $28,125 and $28,125, respectively, in directors’ fees payable that will be paid in common stock. The Company issued no shares of common stock during the three months ended March 31, 2022. Common stock warrants In February 2021, concurrent with sale of common stock, the Company issued warrants to purchase 7,650,000 shares of common stock at an exercise price of $0.85 per share. The warrants are initially exercisable six months following issuance and expire five and one-half years from the issuance date. In connection with the February 2021 sales of common stock, the Company also issued 1,606,500 warrants with an exercise price of $0.85 and 804,000 warrants with an exercise price of $0.46 as commission to the placement agent. The Company issued no warrants to purchase common stock during the three months ended March 31, 2022. The following is a summary of the Company’s warrants to purchase shares of common stock activity: Number of warrants Exercise prices Balance outstanding at December 31, 2020 6,194,899 $ 0.65 Issued 10,060,500 $0.46 - $0.85 Exercised (3,765,477 ) $0.46 - $0.65 Balance outstanding at December 31, 2021 and March 31, 2022 12,489,922 $ 0.75 The composition of the Company’s warrants outstanding at March 31, 2022 is as follows: Number of warrants Exercise Price Expiration Date Remaining life (years) 143,707 $ 0.65 8/12/2022 0.37 2,285,715 0.46 7/31/2025 3.34 804,000 0.46 1/27/2026 3.83 7,650,000 0.85 3/8/2026 4.35 1,606,500 0.85 2/1/2026 3.84 12,489,922

BUSINESS SEGEMENTS

BUSINESS SEGEMENTS	3 Months Ended
	Mar. 31, 2022
BUSINESS SEGEMENTS
11.BUSINESS SEGEMENTS	NOTE 11 – BUSINESS SEGEMENTS The Company is currently organized and managed by four segments, which represent our operating units: United States antimony operations, Mexican antimony operations, precious metals recovery and United States zeolite operations. The Puerto Blanco mill and the Madero smelter at the Company’s Mexico operation bring antimony up to an intermediate or finished stage, which may be sold directly or shipped to the United States operation for finishing at the Thompson Falls, Montana plant. The Puerto Blanco mill in Mexico is the site of our crushing and flotation plant, and a cyanide leach plant which will recover precious metals after the ore goes through the crushing and flotation cycles. A precious metals recovery plant is operated in conjunction with the antimony processing plant at Thompson Falls, Montana, where a 99% precious metals mix will be produced. The zeolite operation produces zeolite near Preston, Idaho. Almost all of the sales of products from the United States antimony and zeolite operations are to customers in the United States, although the Company does have a sales operation in Canada. Total Assets: March 31, 2022 December 31, 2021 Antimony United States $ 24,749,039 $ 24,130,348 Mexico 7,575,114 7,771,515 Subtotal antimony 32,324,153 31,901,863 Precious metals United States 189,567 107,464 Mexico 681,610 782,854 Subtotal precious metals 871,177 890,318 Zeolite 2,344,215 2,210,546 TOTAL $ 35,539,545 $ 35,002,727 For the three months ended Capital expenditures: March 31, 2022 March 31, 2021 Antimony United States $ 28,350 $ - Mexico 16,437 4,872 Subtotal antimony 44,787 4,872 Precious metals 8,380 18,426 Zeolite 135,374 - TOTAL $ 188,541 $ 23,298 Segment operations for the three months ended March 31, 2022 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 2,828,930 $ - $ 2,828,930 $ 77,334 $ 674,042 $ 3,580,306 Depreciation and amortization $ 9,469 $ 138,457 $ 147,926 $ 27,520 $ 44,704 $ 220,150 Income (loss) from operations $ 1,391,512 $ (684,037 ) $ 707,475 $ 49,814 $ 22,291 $ 779,580 Other income (expense) 7,310 - 7,310 - (638 ) 6,672 NET INCOME (LOSS) $ 1,398,822 $ (684,037 ) $ 714,785 $ 49,814 $ 21,653 $ 786,252 Segment operations for the three months ended March 31, 2021 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 657,107 $ - $ 657,107 $ 76,233 $ 519,947 $ 1,253,287 Depreciation and amortization $ 7,891 $ 144,952 $ 152,843 $ 27,604 $ 42,017 $ 222,464 Income (loss) from operations $ (218,669 ) $ (238,568 ) $ (457,237 ) $ 48,630 $ 66,881 $ (341,726 ) Other income (expense) 6,635 - 6,635 - (397 ) 6,238 NET INCOME (LOSS) $ (212,034 ) $ (238,568 ) $ (450,602 ) $ 48,630 $ 66,484 $ (335,488 )

SIGNIFICANT ACCOUNTING POLICI_2

SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES (Policies)
Reclassifications	Certain reclassifications have been made to conform prior periods’ amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported.
COVID -19	The Company’s operations and business have experienced disruption due to the unprecedented conditions surrounding the COVID-19 pandemic spreading throughout the United States and elsewhere, causing disruptions to the Company’s business operations and management. These disruptions are most evident in the Company’s ability to retain and house employees and properly manage them while maintaining proper social distancing and with delays in obtaining materials and supplies. The effects of the continued outbreak of COVID-19 and related government responses could also include extended disruptions to supply chains and capital markets, reduced availability of contractors and a prolonged reduction in economic activity. These effects could have a variety of adverse impacts on the Company, including its ability to conduct operations. The Company has taken steps to mitigate the potential risks to suppliers and employees posed by the spread of COVID-19, including work from home policies where appropriate. The Company will continue to monitor developments affecting both its workforce and contractors, and will take additional precautions as necessary. The ultimate impact of COVID-19 depends on factors beyond management’s knowledge or control, including its duration and third-party actions to contain its spread and mitigate its public health effects. Therefore, the Company cannot estimate the potential future impact to its financial position, results of operations and cash flows, but the impacts could be material.
New Accounting Pronouncements	Accounting standards that have been issued or proposed by the Financial Accounting Standards Board (“FASB”) that do not require adoption until a future date are not expected to have a material impact on the financial statements upon adoption.

EARNINGS PER SHARE (Tables)

EARNINGS PER SHARE (Tables)	3 Months Ended
	Mar. 31, 2022
Net income (loss) per share of common stock:
Antidilutive securities excluded from computation of earnings per share	March 31, 2022 March 31, 2021 Warrants 9,400,207 2,471,089 Convertible preferred stock 1,692,672 1,751,005 TOTAL POSSIBLE DILUTIVE SHARES 11,092,879 4,222,094

REVENUE RECOGNITION (Tables)

REVENUE RECOGNITION (Tables)	3 Months Ended
	Mar. 31, 2022
REVENUE RECOGNITION
Disaggregation of revenue	For the three months ended March 31, 2022 March 31, 2021 Antimony $ 2,828,930 $ 657,107 Zeolite 674,042 519,947 Precious metals 77,334 76,233 TOTAL REVENUE BY PRODUCT $ 3,580,306 $ 1,253,287

INVENTORIES (Tables)

INVENTORIES (Tables)	3 Months Ended
	Mar. 31, 2022
INVENTORIES
Total inventories	March 31, 2022 December 31, 2021 Antimony Metal $ 397,815 $ 234,461 Antimony Oxide 361,797 439,086 Antimony Ore Concentrates 15,222 119,046 Total antimony 774,834 792,593 Zeolite 252,146 262,827 TOTAL INVENTORIES $ 1,026,980 $ 1,055,420

PROPERTIES, PLANTS AND EQUIPM_2

PROPERTIES, PLANTS AND EQUIPMENT (Tables)	3 Months Ended
	Mar. 31, 2022
PROPERTIES, PLANTS AND EQUIPMENT
Major components of the Company's properties	Antimony Segment Zeolite Segment Precious Metals March 31, 2022 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,713,328 $ 8,774,212 $ 3,881,612 $ 1,338,774 $ 15,707,926 Buildings 243,248 613,449 1,093,554 - 1,950,251 Mineral rights and interests - 848,012 - - 848,012 Land and other 2,431,387 2,478,044 16,753 - 4,926,184 4,387,963 12,713,717 4,991,919 1,338,774 23,432,373 Accumulated depreciation (2,742,278 ) (5,761,012 ) (3,359,362 ) (467,597 ) (12,330,249 ) $ 1,645,685 $ 6,952,705 $ 1,632,557 $ 871,177 $ 11,102,124 Antimony Segment Zeolite Segment Precious Metals December 31, 2021 USAC USAMSA BRZ Segment TOTAL Plant and equipment $ 1,684,977 $ 8,757,775 $ 3,853,056 $ 1,330,394 $ 15,626,202 Buildings 243,248 613,449 986,736 - 1,843,433 Mineral rights and interests - 848,012 - - 848,012 Land and other 2,431,387 2,478,044 16,753 - 4,926,184 4,359,612 12,697,280 4,856,545 1,330,394 23,243,831 Accumulated depreciation (2,732,809 ) (5,622,555 ) (3,314,658 ) (440,076 ) (12,110,098 ) $ 1,626,803 $ 7,074,725 $ 1,541,887 $ 890,318 $ 11,133,733

ASSET RETIREMENT OBLIGATION A_2

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Tables)	3 Months Ended
	Mar. 31, 2022
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS
Changes in the asset retirement obligation	Three months ended March 31, 2022 2021 Asset retirement obligation, beginning of period $ 191,149 $ 184,219 Accretion expense 1,732 1,732 Asset retirement obligation, end of period $ 192,881 $ 185,951

DEBT (Tables)

DEBT (Tables)	3 Months Ended
	Mar. 31, 2022
DEBT
Long-term debt	March 31, 2022 December 31, 2021 Promissory note payable to First Security Bank of Missoula, bearing interest at 2.25%, payable in 59 monthly installments of $1,409 with a final payment of $152,726 maturing November 9, 2026; collateralized by a lien on Certificate of Deposit $ 211,093 $ 215,150 Less current portion (12,287 ) (13,230 ) Long term portion $ 198,806 $ 201,920
Principal payments on debt	Twelve months ending March 31, Principal payment 2023 $ 12,287 2024 12,555 2025 12,852 2026 13,144 2027 160,255 $ 211,093

STOCKHOLDERS EQUITY (Tables)

STOCKHOLDERS EQUITY (Tables)	3 Months Ended
	Mar. 31, 2022
STOCKHOLDERS EQUITY (Tables)
Common stock warrant activity	Number of warrants Exercise prices Balance outstanding at December 31, 2020 6,194,899 $ 0.65 Issued 10,060,500 $0.46 - $0.85 Exercised (3,765,477 ) $0.46 - $0.65 Balance outstanding at December 31, 2021 and March 31, 2022 12,489,922 $ 0.75
Warrants outstanding	Number of warrants Exercise Price Expiration Date Remaining life (years) 143,707 $ 0.65 8/12/2022 0.37 2,285,715 0.46 7/31/2025 3.34 804,000 0.46 1/27/2026 3.83 7,650,000 0.85 3/8/2026 4.35 1,606,500 0.85 2/1/2026 3.84 12,489,922

BUSINESS SEGEMENTS (Tables)

BUSINESS SEGEMENTS (Tables)	3 Months Ended
	Mar. 31, 2022
BUSINESS SEGEMENTS
Segment information	Total Assets: March 31, 2022 December 31, 2021 Antimony United States $ 24,749,039 $ 24,130,348 Mexico 7,575,114 7,771,515 Subtotal antimony 32,324,153 31,901,863 Precious metals United States 189,567 107,464 Mexico 681,610 782,854 Subtotal precious metals 871,177 890,318 Zeolite 2,344,215 2,210,546 TOTAL $ 35,539,545 $ 35,002,727
Summary of capital expenditure	For the three months ended Capital expenditures: March 31, 2022 March 31, 2021 Antimony United States $ 28,350 $ - Mexico 16,437 4,872 Subtotal antimony 44,787 4,872 Precious metals 8,380 18,426 Zeolite 135,374 - TOTAL $ 188,541 $ 23,298
Summary of segement operation	Segment operations for the three months ended March 31, 2022 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 2,828,930 $ - $ 2,828,930 $ 77,334 $ 674,042 $ 3,580,306 Depreciation and amortization $ 9,469 $ 138,457 $ 147,926 $ 27,520 $ 44,704 $ 220,150 Income (loss) from operations $ 1,391,512 $ (684,037 ) $ 707,475 $ 49,814 $ 22,291 $ 779,580 Other income (expense) 7,310 - 7,310 - (638 ) 6,672 NET INCOME (LOSS) $ 1,398,822 $ (684,037 ) $ 714,785 $ 49,814 $ 21,653 $ 786,252 Segment operations for the three months ended March 31, 2021 Antimony - USA Antimony -Mexico Total antimony Precious Metals Zeolite Total Total revenues $ 657,107 $ - $ 657,107 $ 76,233 $ 519,947 $ 1,253,287 Depreciation and amortization $ 7,891 $ 144,952 $ 152,843 $ 27,604 $ 42,017 $ 222,464 Income (loss) from operations $ (218,669 ) $ (238,568 ) $ (457,237 ) $ 48,630 $ 66,881 $ (341,726 ) Other income (expense) 6,635 - 6,635 - (397 ) 6,238 NET INCOME (LOSS) $ (212,034 ) $ (238,568 ) $ (450,602 ) $ 48,630 $ 66,484 $ (335,488 )

NATURE OF OPERATIONS (Details N

NATURE OF OPERATIONS (Details Narrative)	3 Months Ended
	Mar. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES (Policies)
Name of Subsidiary 1	Bear River Zeolite Company
Place of Subsidiary 1	Idaho
Owned Percentage 1	75.00%
Owned Remaining Percentage 1	25.00%
Name of Subsidiary 2	Antimonio de Mexico S.A. de C.V
Place of Subsidiary 2	Mexico
Owned Percentage 2	100.00%
Name of Subsidiary 3	Mexico S.A. de C.V
Place of Subsidiary 3	United States
Owned Percentage 3	100.00%
Owned Percentage 4	100.00%
Name of Subsidiary 4	Stibnite Holding Company US Inc
Owned Percentage 5	100.00%
Name of Subsidiary 5	Antimony Mining and Milling US LLC
Place of Subsidiary 5	Delaware
Owned Percentage 6	100.00%
Place of Subsidiary 6	Mexico
Name of Subsidiary 6	Lanxess Laurel de Mexico, S.A. de C.V

EARNINGS PER SHARE (Details)

EARNINGS PER SHARE (Details) - shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Total possible dilution	11,092,879	4,222,094
Cumulative Preferred Stock
Total possible dilution	1,692,672	1,751,005
Warrants
Total possible dilution	9,400,207	2,471,089

EARNINGS PER SHARE (Details Nar

EARNINGS PER SHARE (Details Narrative)	3 Months Ended
	Mar. 31, 2022shares
SIGNIFICANT ACCOUNTING POLICIES (Policies)
Warrants to purchase common stock	149,400

REVENUE RECOGNITION (Details)

REVENUE RECOGNITION (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
TOTAL REVENUE BY PRODUCT	$ 3,580,306	$ 1,253,287
Zeolite
TOTAL REVENUE BY PRODUCT	674,042	519,947
Antimony
TOTAL REVENUE BY PRODUCT	2,828,930	657,107
Precious Metals
TOTAL REVENUE BY PRODUCT	$ 77,334	$ 76,233

REVENUE RECOGNITION (Details Na

REVENUE RECOGNITION (Details Narrative) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
REVENUE RECOGNITION
Accounts receivable	$ 1,475,853	$ 891,314

INVENTORIES (Details)

INVENTORIES (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Inventories	$ 1,026,980	$ 1,055,420
Antimony
Inventories	774,834	792,593
Antimony Metals
Inventories	397,815	234,461
Antimony Oxides
Inventories	361,797	439,086
Antimony Ore Concentrates
Inventories	15,222	119,046
zeolite products
Inventories	$ 252,146	$ 262,827

PROPERTIES, PLANTS AND EQUIPM_3

PROPERTIES, PLANTS AND EQUIPMENT (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Plant and equipment	$ 15,707,926	$ 15,626,202
Buildings	1,950,251	1,843,433
Mineral rights and interests	848,012	848,012
Land & other	4,926,184	4,926,184
Total	23,432,373	23,243,831
Accumulated depreciation	(12,330,249)	(12,110,098)
Properties, plants and equipment, net	11,102,124	11,133,733
Antimony Segment USAC
Plant and equipment	1,713,328	1,684,977
Buildings	243,248	243,248
Mineral rights and interests	0	0
Land & other	2,431,387	2,431,387
Total	4,387,963	4,359,612
Accumulated depreciation	(2,742,278)	(2,732,809)
Properties, plants and equipment, net	1,645,685	1,626,803
Antimony Segment USAMSA
Plant and equipment	8,774,212	8,757,775
Buildings	613,449	613,449
Mineral rights and interests	848,012	848,012
Land & other	2,478,044	2,478,044
Total	12,713,717	12,697,280
Accumulated depreciation	(5,761,012)	(5,622,555)
Properties, plants and equipment, net	6,952,705	7,074,725
Zeolite Segment BRZ
Plant and equipment	3,881,612	3,853,056
Buildings	1,093,554	986,736
Mineral rights and interests	0	0
Land & other	16,753	16,753
Total	4,991,919	4,856,545
Accumulated depreciation	(3,359,362)	(3,314,658)
Properties, plants and equipment, net	1,632,557	1,541,887
Precious Metals Segment
Plant and equipment	1,338,774	1,330,394
Buildings	0	0
Mineral rights and interests	0	0
Land & other	0	0
Total	1,338,774	1,330,394
Accumulated depreciation	(467,597)	(440,076)
Properties, plants and equipment, net	$ 871,177	$ 890,318

PROPERTIES, PLANTS AND EQUIPM_4

PROPERTIES, PLANTS AND EQUIPMENT (Details Narrative) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
PROPERTIES, PLANTS AND EQUIPMENT (Details)
Assets not yet placed in service	$ 956,965	$ 665,175

ASSET RETIREMENT OBLIGATION A_3

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details)
Asset retirement obligation, beginning of period	$ 191,149	$ 184,219
Accretion Expense	1,732	1,732
Asset retirement obligation, end of period	$ 192,881	$ 185,951

ASSET RETIREMENT OBLIGATION A_4

ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details Narrative) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
ASSET RETIREMENT OBLIGATION AND ACCRUED RECLAMATION COSTS (Details)
Asset retirement obligation liability with reclamation obligations	$ 300,318	$ 298,649
Reclamation obligations	$ 107,500

DEBT (Details)

DEBT (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Less current portion	$ (12,287)	$ (13,230)
Noncurrent portion	198,806	201,920
First Security Bank of Missoula
Total debt	$ 211,093	$ 215,150

DEBT (Details 1)

DEBT (Details 1)	Mar. 31, 2022USD ($)
DEBT
2023	$ 12,287
2024	12,555
2025	12,852
2026	13,144
2027	160,255
Total	$ 211,093

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Royalty expense	$ 62,030	$ 62,130
Accrued liabilities	1,270		$ 0
Accrued royalties payable	$ 381,054		$ 346,242
Minimum [Member]
Royalties percentage	8.00%
Maximum [Member]
Royalties percentage	13.00%

STOCKHOLDERS EQUITY (Details)

STOCKHOLDERS EQUITY (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Number of warrants, beginning	12,489,922	6,194,899
Issued	0	10,060,500
Exercised	0	(3,765,477)
Number of warrants, ending	12,489,922	12,489,922
Exercise prices, Balance outstanding, Beginning Balance	$ 0.75	$ 0.65
Exercise prices, Balance outstanding, Ending Balance	$ 0.75	0.75
Minimum [Member]
Issued		0.46
Exercised		0.46
Maximum [Member]
Issued		0.85
Exercised		$ 0.65

STOCKHOLDERS EQUITY (Details 1)

STOCKHOLDERS EQUITY (Details 1)	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Warrants
Shares	12,489,922
Warrant 1
Shares	143,707
Exercise Price | $ / shares	$ 0.65
Remaining life	4 months 13 days
Expiration date	8/12/2022
Warrant 2
Shares	2,285,715
Exercise Price | $ / shares	$ 0.46
Remaining life	3 years 4 months 2 days
Expiration date	7/31/2025
Warrant 3
Shares	804,000
Exercise Price | $ / shares	$ 0.46
Remaining life	3 years 9 months 29 days
Expiration date	1/27/2026
Warrant 4
Shares	7,650,000
Exercise Price | $ / shares	$ 0.85
Remaining life	4 years 4 months 6 days
Expiration date	3/8/2026
Warrant 5
Shares	1,606,500
Exercise Price | $ / shares	$ 0.85
Remaining life	3 years 10 months 2 days
Expiration date	2/1/2026

STOCKHOLDERS EQUITY (Details Na

STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	Feb. 03, 2021	Feb. 18, 2021	Mar. 31, 2022	Mar. 31, 2021
common stock Issued			3,723,810
Not issue, common stock with a value			$ 1,763,619
Directors' fees payable			$ 28,125	$ 28,125
Warrant 2
Warrants sold to purchase shares of common stock			804,000
Warrants, exercise price			$ 0.46
Common Stock Warrants
Warrants sold to purchase shares of common stock	7,650,000		1,606,500
Warrants, exercise price	$ 0.85		$ 0.85
February 2021 [Member]
Common stock shares sold	15,300,000	10,990,000
Total cash issuance cost			$ 1,654,820
Shares sold price per share	$ 0.70	$ 1.30
Gross proceeds from shares sold	$ 10,710,000	$ 14,287,000

BUSINESS SEGEMENTS (Details)

BUSINESS SEGEMENTS (Details) - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Total assets	$ 35,539,545	$ 35,002,727
United States Precious Metals
Total assets	189,567	107,464
Zeolite
Total assets	2,344,215	2,210,546
United States Antimony
Total assets	24,749,039	24,130,348
Mexico Antimony
Total assets	7,575,114	7,771,515
Subtotal Antimony
Total assets	32,324,153	31,901,863
Mexico Precious Metals [Member]
Total assets	681,610	782,854
Subtotal Precious Metals [Member]
Total assets	$ 871,177	$ 890,318

BUSINESS SEGEMENTS (Details 1)

BUSINESS SEGEMENTS (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Capital expenditures	$ 188,541	$ 23,298
Precious Metals
Capital expenditures	8,380	18,426
Zeolite
Capital expenditures	135,374	0
United States Antimony
Capital expenditures	28,350	0
Mexico Antimony
Capital expenditures	16,437	4,872
Subtotal Antimony
Capital expenditures	$ 44,787	$ 4,872

BUSINESS SEGEMENTS (Details 2)

BUSINESS SEGEMENTS (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenues	$ 3,580,306	$ 1,253,287
Depreciation and amortization	220,150	222,464
Income (loss) from operations	779,580	(341,726)
Total other income (expense)	6,672	6,238
NET INCOME (LOSS)	786,252	(335,488)
Zeolite
Revenues	674,042	519,947
Depreciation and amortization	44,704	42,017
Income (loss) from operations	22,291	66,881
Total other income (expense)	(638)	(397)
NET INCOME (LOSS)	21,653	66,484
United States Antimony
Revenues	2,828,930	657,107
Depreciation and amortization	9,469	7,891
Income (loss) from operations	1,391,512	(218,669)
Total other income (expense)	7,310	6,635
NET INCOME (LOSS)	1,398,822	(212,034)
Mexico Antimony
Revenues	0	0
Depreciation and amortization	138,457	144,952
Income (loss) from operations	(684,037)	(238,568)
Total other income (expense)	0	0
NET INCOME (LOSS)	(684,037)	(238,568)
Subtotal Antimony
Revenues	2,828,930	657,107
Depreciation and amortization	147,926	152,843
Income (loss) from operations	707,475	(457,237)
Total other income (expense)	7,310	6,635
NET INCOME (LOSS)	714,785	(450,602)
Precious Metals
Revenues	77,334	76,233
Depreciation and amortization	27,520	27,604
Income (loss) from operations	49,814	48,630
Total other income (expense)	0	0
NET INCOME (LOSS)	$ 49,814	$ 48,630